Belzutifan is an inhibitor of HIF-2α. It’s used to treat RCC linked to VHL and helps lower tumor hypoxia. You can get it in 40 mg tablets.
The usual dose is 120 mg, taken just once every day. The tablets come in bottles with 90 pills in each. The drug is made to go after and stop HIF-2α, which is a protein super important in how RCC grows and gets worse.
By lowering HIF-2α levels, belzutifan helps make the tumor less low on oxygen, which might make patients feel better. You take these pills by mouth and make sure to swallow them whole with a glass of water. You gotta stick to the dose your doc tells you, and don’t change it without talking to a healthcare provider first.
